Fil LTD Emergent Bio Solutions Inc. Transaction History

Fil LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$52.05 - $66.51 $5.06 Million - $6.47 Million	-97,271 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$48.33 - $55.64 $2.06 Million - $2.37 Million	-42,525 Reduced 30.42%	97,271 $4.91 Million
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $5.72 Million - $7 Million	-128,624 Reduced 47.92%	139,796 $7.36 Million
Q4 2017 Feb 12, 2018	SELL	$37.77 - $47.75 $10.1 Million - $12.8 Million	-267,258 Reduced 49.89%	268,420 $12.5 Million
Q3 2017 Nov 13, 2017	SELL	$34.14 - $40.45 $2.17 Million - $2.57 Million	-63,565 Reduced 10.61%	535,678 $21.7 Million
Q2 2017 Aug 29, 2017	BUY	N/A	599,243	599,243 $20.3 Million

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $443M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.